Nemucore Medical Innovations, Inc.
Tim Coleman is an accomplished entrepreneur and executive with extensive experience in healthcare innovation and personalized medicine. Currently serving as COO and Co-founder at O'Ryan Health and Co-founder and President of NOVA PreVita, Tim focuses on advancing pediatric healthcare and enhancing preventive cardiology. Tim also co-founded Hydrangea Island Trading Company and founded Nemucore Medical Innovations, a company dedicated to developing effective cancer treatments. Previous roles include Chief of Staff at Gladius Therapeutics, COO at Second Bloom HQ, and various leadership positions at Mending Minds Foundation and PricewaterhouseCoopers. Tim holds a Ph.D. in Molecular Biophysics & Biochemistry from Virginia Commonwealth University, an MBA in Finance & Entrepreneurship from Boston University, and a B.S. in Biochemistry from Worcester Polytechnic Institute.
This person is not in any teams
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations Inc is dedicated to the improvement of patient care by developing safe, effective molecularly targeted therapies. By working to know every patient we treat, and engaging patient advocacy groups in constructive ways to enhance patient quality of life, Nemucore is dedicated to forwarding knowledge of molecularly targetedtherapies to become a leader in the development of revolutionary life saving products for improving cancer patient care.